US 12,133,848 B2
Oral product
Feng Gao, Midlothian, VA (US); Frank Scott Atchley, Midlothian, VA (US); Gregory James Griscik, Midlothian, VA (US); Christopher Joseph Dinovi, Ruther Glen, VA (US); Phillip M. Hulan, Midlothian, VA (US); Diane L. Gee, Chesterfield, VA (US); Jason Flora, Richmond, VA (US); and Shuzhong Zhuang, Glen Allen, VA (US)
Assigned to Altria Client Services LLC, Richmond, VA (US)
Filed by Altria Client Services LLC, Richmond, VA (US)
Filed on Dec. 5, 2022, as Appl. No. 18/061,680.
Application 18/061,680 is a continuation of application No. 16/942,014, filed on Jul. 29, 2020, granted, now 11,517,566, issued on Dec. 6, 2022.
Application 16/942,014 is a continuation of application No. 16/214,490, filed on Dec. 10, 2018, granted, now 10,780,085, issued on Sep. 22, 2020.
Application 16/214,490 is a continuation of application No. 14/940,698, filed on Nov. 13, 2015, granted, now 10,183,016, issued on Jan. 22, 2019.
Application 14/940,698 is a continuation of application No. 14/274,916, filed on May 12, 2014, granted, now 9,185,931, issued on Nov. 17, 2015.
Claims priority of provisional application 61/822,596, filed on May 13, 2013.
Prior Publication US 2023/0097809 A1, Mar. 30, 2023
Int. Cl. A24B 13/00 (2006.01); A24B 15/14 (2006.01); A24B 15/16 (2020.01); A24B 15/30 (2006.01); A61J 3/10 (2006.01); A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 31/465 (2006.01); A61K 36/81 (2006.01); A61K 45/06 (2006.01); B29C 48/00 (2019.01); B29K 75/00 (2006.01); B29K 401/00 (2006.01); B29K 407/00 (2006.01); B29L 31/00 (2006.01)
CPC A61K 31/465 (2013.01) [A24B 15/14 (2013.01); A24B 15/16 (2013.01); A24B 15/30 (2013.01); A24B 15/308 (2013.01); A61J 3/10 (2013.01); A61K 9/0053 (2013.01); A61K 9/2013 (2013.01); A61K 9/2031 (2013.01); A61K 9/205 (2013.01); A61K 9/2054 (2013.01); A61K 9/2095 (2013.01); A61K 36/81 (2013.01); A61K 45/06 (2013.01); B29C 48/0011 (2019.02); B29C 48/0022 (2019.02); B29C 48/022 (2019.02); B29K 2075/00 (2013.01); B29K 2401/00 (2013.01); B29K 2407/00 (2013.01); B29L 2031/753 (2013.01)] 20 Claims
OG exemplary drawing
 
1. An oral product comprising:
a mouth-stable polymer in an amount of 40 weight percent to 80 weight percent;
a cellulosic material in an amount of greater than or equal to 10 weight percent;
a mouth-soluble binder in an amount of 0.1 weight percent to 5 weight percent;
triglycerides in an amount of less than or equal to 20 weight percent; and
nicotine or a nicotine derivative, the oral product having a springiness of greater than or equal to 20 weight percent.